Abstract
Epidemiology and clinical observations of fetal programming

121
Dörner was among the first to provide epidemiological evidence that gestational to increase its own insulin production, generally leading to excessively growth, a 141 condition known as large for gestation age or macrosomic fetus [3, 49] 
155
Given the increasing prevalence of "diabesity" among women of reproductive age in 156 developed and Westernized developing countries, this may decisively contribute to M A N U S C R I P T A C C E P T E D 
Placental role in GDM
202
The placenta fulfills several critical roles during pregnancy: not only is the regulator 
325
Recent studies have explored the role of epigenetics in offspring exposed to GDM. with DNA methylation as a mediator of this association [87] . This study supports that 344 maternal glycemia leads to epigenetic adaptations in the LEP region of the offspring, 345 potentially contributing to long-term programming of excessive adiposity later in life.
346
Although these studies provide exciting insights into possible epigenetic signatures 347 that may contribute to long-term programming of obesity and metabolic disorders, 348 one has to bear in mind that small samplings were included and these studies also 349 lack of independent replication, hence the methylation changes detected often do not 350 reach biological levels of significance.
351
It is relevant to mention that children whose mothers had diabetes during pregnancy 352 are at increased risk of becoming obese and developing diabetes at young ages. 
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The HAPO study has firmly established that maternal hyperglycemia, even at levels 
Highlights
• Gestational diabetes prevalence is increasing globally.
• Fetal programming predisposes for future diseases in diabetic mothers and offspring.
• Need to stablish perinatal management and postpartum diabetes prevention strategies.
• Long term complications could be predicted by early-pregnancy diagnostic models for GDM.
